Wuhan BBT Medical Technology Development Co., Ltd.
Founded in 2002 and based in Wuhan’s “China Optics Valley” innovation zone, BBT Medical is a high-tech enterprise focused on minimally invasive medical technology: research and development, manufacturing, sales, and clinical support.
Our portfolio includes RF ultrasonic scalpels, ultrasonic soft-tissue cutting systems, image-guided ablation platforms, self-coagulation RF therapy systems, matrix RF pelvic floor systems, vacuum-assisted breast biopsy systems, and related accessories. Applications span gynecology, general surgery, ENT, thyroid, hepatobiliary, gastrointestinal hemostasis, medical aesthetics, and veterinary surgery, supporting minimally invasive care across specialties.
The company maintains ISO 13485:2016 and EU CE certifications. In 2022 our ultrasonic surgical system was selected for the national Excellent Domestic Medical Equipment Product Catalog. BBT was recognized as a provincial “Little Giant” specialized enterprise. Core technologies are protected by independent intellectual property. We served as the first drafter of China’s industry standard for gynecological radio frequency therapy instruments.
Through continuous innovation and integration of resources, BBT products are trusted in China and abroad; our RF ultrasonic platform leads domestic adoption and is exported to Russia, Brazil, Turkey, India, South Korea, and many other countries. Our mission: Healthy Half the Sky, Benefiting All Mankind — advancing comprehensive minimally invasive surgery with solutions from prevention and diagnosis to treatment and recovery.
Corporate presence and technology campus (source: bbt2000.com)